Leerink Partners Remains Bullish After Opdivo and HCV Help Drive 3Q Beat for Bristol-Myers Squibb (BMY)
Go back to Leerink Partners Remains Bullish After Opdivo and HCV Help Drive 3Q Beat for Bristol-Myers Squibb (BMY)| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.58 -0.04 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.62 | 52 Week High | $77.12 | |||
| Open | $62.73 | 52 Week Low | $49.03 | |||
| Day High | $62.77 | P/E | 40.64 | |||
| Day Low | $62.03 | EPS | $1.54 | |||
| Volume | 575,237 | |||||
